TORONTO, ON / ACCESSWIRE / October 14, 2022 / NuGen Medical Devices Inc. (TSXV:NGMD)(OTCQB:NGMDF) ("NuGen'' or the "Company"), a leader in needle-free drug delivery, is pleased to announce the appointment of Erik Emerson to the Company's Advisory Board.
Erik Emerson has over 20 years of pharmaceutical and biotechnology experience. Currently, he serves as the managing partner of KCNT LLC consulting and principal of Pharmacense, a company that provides corporate development and strategic planning services for life science companies. Erik has held various C-level positions, including CEO and CCO for both public and private pharmaceutical and biotech organizations including Mezzion Pharmaceuticals, and has worked in varying commercial and business development capacities for XOMA, Gilead, and King Pharmaceuticals.
Erik has been involved in multiple launches during his time at King, Gilead, Symplmed, and BioMauris. While at XOMA, he worked to identify the most appropriate needle-free device for the pending launch of their proprietary biologic therapy. He also launched Letairis (ambrisentan) for Pulmonary Hypertension while at Gilead that included a novel safety monitoring program called Lab Sync.
"Erik brings a creative approach to commercialization, patient engagement, and corporate partnerships," said NuGen CEO Michael Wright. "We look forward to working with him and our growing advisory team as NuGen continues to develop our innovative medical delivery products."
About NuGen Medical Devices
NuGen is an emerging specialty medical device company developing the next generation of needle-free technologies and other innovative medical delivery products. The company's products, which include the InsuJet™ and PetJet™ needle-free injection systems, are designed to improve the lives of millions of people and animals. NuGen continues to receive approval in numerous countries, including Canada. NuGen's products are designed for use in several important fields including, but not limited to, diabetes, veterinary medicine, and vaccines.
For More Information visit: www.nugenmd.com
Twitter: @NuGenMD
LinkedIn: https://www.linkedin.com/company/nugenmd/
For further information, please contact:
Michael Wright
President and CEO
NuGen Medical Devices Inc.
mw@nugenmd.com
Investor Relations Contact:
Kin Communications Inc.
NGMD@kincommunications.com
(604) 684-6730
Twitter: @KinComm
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
This news release contains forward-looking information which is subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ from those projected in the forward-looking statements. Forward looking statements in this press release include the Company's 2022 objectives of securing additional distribution and sales agreements, making submissions for regulatory approvals and capitalizing on additional market opportunities. These forward-looking statements are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking information. The forward-looking information contained herein is given as of the date hereof and the Company assumes no responsibility to update or revise such information to reflect new events or circumstances, except as required by law.
SOURCE: NuGen Medical Devices
View source version on accesswire.com:
https://www.accesswire.com/720451/NuGen-MD-Welcomes-Erik-Emerson-to-its-Advisory-Board
Related Quotes
Every investor in DXP Enterprises, Inc. ( NASDAQ:DXPE ) should be aware of the most powerful shareholder groups. And…
Investing in stocks comes with the risk that the share price will fall. And unfortunately for E2open Parent Holdings…
Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see AZZ Inc…
The latest price moves in bitcoin (BTC) and crypto markets in context for Oct. 14, 2022. First Mover is CoinDesk’s daily newsletter that contextualizes the latest actions in the crypto markets.
Cowen Vice President Equity Research Michael Nedelcovych joins Yahoo Finance Live to discuss Elon Musk touting a prescription weight-loss drug, the company Novo Nordisk, and U.S. adults living with obesity.
The FDA has announced that there may be a shortage of some generic versions of the ADHD drug Adderall due to manufacturing delays. Here’s what people can do if they’re having trouble filling their prescriptions.
LONDON (Reuters) -Investors piled cash into sterling money-market funds at more than three times their usual rate during the recent turbulence in British bond markets, and pension funds likely made up the bulk of those inflows, Fitch Ratings said on Friday. The government's "mini-Budget" on Sept. 23 triggered some of the biggest ever jumps in UK government bond yields, spooked wider markets and triggered a crisis among pension funds needing to find cash. Money market funds typically invest in high quality assets over a shorter-term horizon than other asset managers and, as such, are perceived to carry lower risk.
Binance is launching a $500 million project to support Bitcoin miners and infrastructure providers facing massive losses the fall of crypto prices this past year.
The situation is further disrupting the economics of a sector already hit by low crypto prices and high energy costs.
Proposed regulations related to required minimum distributions from inherited IRAs were confusing. But the IRS has provided much-needed clarity and tax relief.
This week’s worse-than-expected inflation report led to turmoil in more than one market, but you only read about one of them. What got far less attention was the flurry of excitement that the inflation report caused in the normally-staid I-bond market.
The core CPI inflation rate hit a 40-year high, raising Fed rate hike targets. The Dow Jones dived, rebounded as yields soared and fell back.
Reliance Steel & Aluminum stock is forming a base showing a 211.75 buy point with its next quarterly EPS report set for Oct. 27. The entry is based on a second-stage consolidation. The metal fabricator stock has 91 Relative Strength Rating.
MILAN (Reuters) -Italy's Monte dei Paschi di Siena (MPS) said a new share sale to raise up to 2.5 billion euros ($2.4 billion) would cost it 125 million euros in fees to financial institutions backstopping the issue. After difficult negotiations that risked derailing the capital raising, the eight banks have agreed to guarantee the share issue for up to 807 million euros. Algebris is backstopping up to another 50 million euros.
High inflation readings from the U.S. Bureau of Labor Statistics have turned investors off of crypto for the moment.
Rupert Murdoch has started a process that could reunite his media empire, News Corp and Fox Corp disclosed on Friday, saying they would consider combining at his behest, nearly a decade after the companies split. If a deal goes through, the combination will allow Murdoch greater control over his media assets and help the companies trim costs. Media companies are fighting decades-low growth in advertising sales and for users' attention against deep-pocketed social media and content websites.
Twenty million people, or nearly 45% of federal student loan borrowers, will see their debt wiped away through President Joe Biden’s student loan cancellation, according to an August press release by the White House. “January is going to be here before you know it,” says Damian Dunn, a certified financial planner and vice president of corporate financial wellness platform Your Money Line. Payment amounts and options could be different.
Investing in certain stocks can pay off in the long run, especially if you hold on for a decade or more.
CHS, GEF and AX made it to the Zacks Rank #1 (Strong Buy) value stocks list on October 14, 2022.
Oracle stock rallied last year, but the company’s $28 billion deal for Cerner has made investors nervous. Why Oracle remains bullish on the deal.